日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm

Pivekimab Sunirine 治疗浆细胞样树突状细胞肿瘤

Pemmaraju, Naveen; Marconi, Giovanni; Montesinos, Pau; Lane, Andrew A; Mazzarella, Luca; Sallman, David A; Ulrickson, Matthew L; Schiller, Gary J; Erba, Harry P; Wang, Eunice S; Walter, Roland B; Deconinck, Eric; Aribi, Ahmed; Legrand, Ollivier; Lebon, Delphine; Maisano, Valerio; Martinelli, Giovanni; DeAngelo, Daniel J; Derenzini, Enrico; Du, Yining; Lakshmikanthan, Sribalaji; Potluri, Jalaja; Kantarjian, Hagop M; Daver, Naval G

Highly effective combination of BRG1/BRM inhibitor with BET inhibitor or decitabine for high-risk MECOM-rearranged AML

BRG1/BRM抑制剂联合BET抑制剂或地西他滨治疗高危MECOM重排急性髓系白血病疗效显著。

Fiskus, Warren; Mill, Christopher P; Piel, Jessica; Collins, Mike; Hentemann, Murphy; Cuglievan, Branko; Birdwell, Christine E; Das, Kaberi; Davis, John A; Hou, Hanxi; Jain, Antrix; Malovannaya, Anna; Flores, Lauren B; Kadia, Tapan M; Daver, Naval; Sasaki, Koji; Takahashi, Koichi; Hammond, Danielle; Wang, Jian; Loghavi, Sanam; Su, Xiaoping; DiNardo, Courtney D; Delwel, Ruud; Bhalla, Kapil N

Outcomes of therapy-related non-core binding factor acute myeloid leukemia with venetoclax-based therapies

维奈托克治疗相关非核心结合因子急性髓系白血病的疗效

Senapati, Jayastu; Croden, Jennifer; Garcia-Manero, Guillermo; Takahashi, Koichi; Daver, Naval G; Kadia, Tapan M; Borthakur, Gautam; Short, Nicholas James; Jabbour, Elias; Haddad, Fadi; Marvin-Peek, Jennifer; Abbas, Hussein A; Bose, Prithviraj; Tang, Guilin; Loghavi, Sanam; Shpall, Elizabeth J; Ramdial, Jeremy; Popat, Uday R; Champlin, Richard E; Ravandi, Farhad; Kantarjian, Hagop M; Dinardo, Courtney D

BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML

基于BET抑制剂的联合疗法靶向MECOM重排(r) AML中的新型依赖性

Birdwell, Christine E; Fiskus, Warren; Mill, Christopher P; Kadia, Tapan M; Daver, Naval; DiNardo, Courtney D; Sasaki, Koji; Davis, John A; Das, Kaberi; Hou, Hanxi; Jain, Antrix; Malovannaya, Anna; Flores, Lauren B; Pourebrahim, Rasoul; Yuan, Selina; Su, Xiaoping; Ceribelli, Michele; Bhalla, Kapil N

Impact of allogeneic stem cell transplantation in patients with higher risk myelodysplastic syndromes

异基因造血干细胞移植对高危骨髓增生异常综合征患者的影响

Bazinet, Alexandre; Bataller, Alex; Chien, Kelly; Sasaki, Koji; Montalban-Bravo, Guillermo; Hammond, Danielle; Bouligny, Ian; Swaminathan, Mahesh; Jen, Wei Ying; Kugler, Eitan; Kanagal-Shamanna, Rashmi; Kadia, Tapan; Borthakur, Gautam; DiNardo, Courtney; Short, Nicholas; Pemmaraju, Naveen; Jabbour, Elias; Daver, Naval; Ravandi, Farhad; Urrutia, Samuel; Gener-Ricos, Georgina; Braish, Julie; Briski, Robert; Rodriguez-Sevilla, Juan Jose; Li, Ziyi; Champlin, Richard E; Shpall, Elizabeth J; Alousi, Amin; Oran, Betul; Hosing, Chitra; Ramdial, Jeremy L; Olson, Amanda; Pierce, Sherry; Chen, Julianne; Kantarjian, Hagop; Garcia-Manero, Guillermo; Popat, Uday

Long-term outcomes in FLT3-mutated acute myeloid leukemia after frontline hypomethylating agent, venetoclax and a FLT3 inhibitor

一线去甲基化药物维奈托克联合FLT3抑制剂治疗FLT3突变型急性髓系白血病患者的长期疗效

Short, Nicholas J; Loghavi, Sanam; Yilmaz, Musa; Karrar, Omer; Kim, Kunhwa; Dinardo, Courtney D; Kadia, Tapan M; Maroun, Manuel; Borthakur, Gautam; Issa, Ghayas C; Jabbour, Joseph; Oran, Betul; Shpall, Elizabeth J; Popat, Uday; Patel, Keyur P; Routbort, Mark; Konopleva, Marina; Ravandi, Farhad; Kantarjian, Hagop; Daver, Naval

The limitations and fallacies of relying on glycosylated hemoglobin for diagnosing and monitoring diabetes in Indian populations

在印度人群中,依赖糖化血红蛋白诊断和监测糖尿病的局限性和谬误

Samajdar, Shambo Samrat; Joshi, Shashank R; Misra, Anoop; Vikram, Naval K

Glycated haemoglobin for diagnosing and monitoring diabetes in Indian populations-authors' reply

糖化血红蛋白在印度人群糖尿病诊断和监测中的应用——作者回复

Samajdar, Shambo Samrat; Joshi, Shashank R; Misra, Anoop; Vikram, Naval K

Neurodegeneration, Oxidative Stress, NGF/TrkA/P75(NTR), and PGE2 Dysregulation Induced by PFOS Single and Repeated Treatment: Partial Protection by T3 and Other Therapeutic Approaches.

PFOS 单次和重复治疗引起的神经退行性变、氧化应激、NGF/TrkA/P75(NTR) 和 PGE2 失调:T3 和其他治疗方法的部分保护作用。

Moyano Paula, Flores Andrea, Sanjuan Javier, Plaza José Carlos, Guerra-Menéndez Lucía, Naval María Victoria, Abascal Luisa, Mateo-Sierra Olga, Del Pino Javier

A phase I, single-arm, open-label, dose-escalation, multicenter study of SAR445419, an off-the-shelf, ex vivo expanded allogeneic natural killer cell product, in participants with relapsed or refractory acute myeloid leukemia

一项针对复发或难治性急性髓系白血病患者的 I 期、单臂、开放标签、剂量递增、多中心研究,旨在评估 SAR445419(一种现成的、体外扩增的异基因自然杀伤细胞产品)的疗效。

Konopleva, Marina; Bhatt, Vijaya Raj; Mantzaris, Ioannis; Maiti, Abhishek; Gundabolu, Krishna; Schafer, Jolie; Jensen, Kyle; Saleem, Rao; Li, Yi; Drewniak, Agata; Bay, Pierre; Huh, Winston; Yildirim, Ozlem; Abbadessa, Giovanni; Cooley, Sarah; Daver, Naval